The immune systems of infected patients have demonstrated important changes, such as lower effector T cells, loss of the antiviral capacity of CD8+ T lymphocytes and natural killer cells (NK), and the excessive release of inflammatory mediators, which may contribute to the disease severity and difficulty in establishing an effective treatment (9, 10).